Revvity, Inc. (RVTY) Launches CE-IVDR T1D Screening Kit in Europe
Revvity launched the GSP T1D 3plex kit, a fully automated, CE—IVDR—certified autoantibody test for early T1D risk detection, processed on its GSP instrument. It will be available in Europe and other CE IVD markets; not FDA—cleared.Material DetailsContext by AI AnalystThis extends Revvity’s diagnost…